<DOC>
	<DOCNO>NCT01495169</DOCNO>
	<brief_summary>Tolerability , undertstanding action drug body , understanding effect drug adolescent patient need treatment antipsychotic medication</brief_summary>
	<brief_title>Tolerability Pharmacokinetics Iloperidone Adolescent Patients</brief_title>
	<detailed_description />
	<criteria>male female 1217 year age . stable housing situation guardian/parent encourage compliance study protocol . diagnosis disorder require treatment antipsychotic agent . Children 's Global Assessment Severity Scale ( CGAS ) 41 great . Heart rate &lt; /=100 beat per minute &gt; /= 50 beat per minute . Patients mild , moderate severe mental retardation ( i.e. , document IQ &lt; 70 ) , capacity assent , understand inform consent , participate fully assessment . Hospitalized due suicidal ideation suicidal behavior , history suicidal ideation within 6 month prior screen , history suicidal behavior within 2 year prior screen . Pregnant , females become pregnant lactating female . Known hypersensitivity iloperidone relate drug . Clinical condition ( Neurological , metabolic , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal urological ) , may pose significant risk patient impair reliable study participation . Clinically unstable cardiac disease , structural cardiac abnormality , congential long QT syndrome , clinically significant ECG abnormality screen ( PR interval &gt; 240 m , QTcF &gt; 450 m , QRS duration &gt; /= 100 m ) arrhythmia . Syncope , near syncope , palpitation . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Antipsychotic</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Bipolar disorder</keyword>
	<keyword>Iloperidone</keyword>
</DOC>